Novo Ventures 1 A/S

Novo Ventures 1 A/S

Novo Ventures 1 A/S

Overview
Date Founded

1999

Headquarters

Tuborg Havnevej 19,Hellerup, Capital Region 2900

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Private Equity & Venture Capital
Accounting & Financial Services
Investment Services & Portfolio Management

Company Description

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Website

http://www.novoholdings.dk/investments/ventures/

Contact Data
Trying to get in touch with decision makers at Novo Ventures 1 A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
November 9, 2020
Stargazer Pharmaceuticals, Inc. Announces $57 Million Series A Financing and Initiation of a Phase 2a Clinical Study of STG-001 in Stargardt Disease Patients; Financing will enable Stargazer to advance development of STG-001 through a pivotal clinical stu
Business Wire
September 17, 2020
LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs; Funding to support advancement of powerful bispecific gamma-delta T cell engager programs for the treatment of a broad range of cancers; New investors in
Business Wire
June 3, 2020
NodThera Announces Close of $55 Million Series B Financing; Financing round led by Novo Ventures and includes new investors Cowen Healthcare Investments and Sanofi Ventures, as well as existing investors 5AM Ventures, F-Prime Capital, Sofinnova Partners a
Business Wire
November 19, 2019
Novo Ventures and Broad Institute of MIT and Harvard Launch Drug Discovery "Greenhouse" to Drive Creation of Innovative New Therapies; Partnership supports groundbreaking science through critical early stages of drug discovery
Business Wire
October 8, 2019
Swift Health Systems Raises $45 Million in Series C Funding; INBRACE Truly Invisible Braces Are Set to Disrupt the Orthodontic Market

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Thomas Dyrberg

Managing Partner

Tiba Aynechi

Senior Partner

Martin Edwards

Senior Partner

Tatiana Brask

Senior Partner

Naveed I. Siddiqi

Partner

Jørgen Søberg Petersen

Venture Partner

Nanna Lüneborg

Partner

Max Løwe

Controller

Nilesh Kumar

Senior Principal

Morten Aleksandr Engel

Asset Director

Trending People
Rosen~Harbottle
VRM INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Vroom, Inc... - PR Newswire
Rosen Law Firm
VRM INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Vroom, Inc... - PR Newswire
Royal Navy
Prince Philip: The Royal Navy years - BBC
U.S. Department of Defense
Biden sets budget wish list - St. Louis Post-Dispatch (Missouri)
United States Department of Health & Human Services
Biden sets budget wish list - St. Louis Post-Dispatch (Missouri)
Trending Organizations
Rosen~Harbottle
VRM INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Vroom, Inc... - PR Newswire
Rosen Law Firm
VRM INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Vroom, Inc... - PR Newswire
Royal Navy
Prince Philip: The Royal Navy years - BBC
U.S. Department of Defense
Biden sets budget wish list - St. Louis Post-Dispatch (Missouri)
United States Department of Health & Human Services
Biden sets budget wish list - St. Louis Post-Dispatch (Missouri)
Paths to Novo Ventures 1 A/S
Potential Connections via
Relationship Science
You
Novo Ventures 1 A/S
Recent Transactions
Details Hidden

Anokion SA purchases Kanyos Bio, Inc. from Versant Venture Management LLC, Novartis Venture Fund, Astellas Venture Management LLC, Novo Ventures 1 A/S

Details Hidden

Pfizer, Inc. purchases TherAchon SAS from Sofimac Innovation SAS, New Enterprise Associates, Pfizer Venture Investments, Versant Venture Management LLC, BPIFrance Investissement SAS, OrbiMed Advisors Private Equity, Novo Ventures 1 A/S, Triartisan Capital Advisors LLC

Details Hidden

Smith & Nephew Plc purchases Ceterix Orthopaedics, Inc. from Versant Venture Management LLC, 5AM Venture Management LLC, Novo Ventures 1 A/S

Advisors & Consultants
Legal Advisor
Jennifer D. Knapp

Partner at Wilson Sonsini Goodrich & Rosati PC
Investments
Details Hidden
Aristea Therapeutics, Inc.

Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA.

Details Hidden
Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc. engages in the development of novel therapeutics and deoxyribonucleic acid repair and synthetic lethal therapies. It exploits the synthetic lethality of gain-of-function DNA-damaging genes and DNA repair inhibition, resulting in selective death among cells. The company was founded by Kevin Mills and Timothy Romberger and is headquartered in Lexington, MA.

Details Hidden
Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Novo Ventures 1 A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Novo Ventures 1 A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Novo Ventures 1 A/S.